Privi Speciality Chemicals (PRIVISCL) Q2 25/26 earnings summary

Executive summary

• Achieved record financial and operational performance in Q2 and H1 FY2026, with revenue growth of 26% YoY for Q2 and 24% YoY for H1, driven by flagship and new products, robust demand, and operational efficiencies.

• Recognized for sustainability with first prize at EFIAT 2025 and a Platinum EcoVadis rating, placing among the top 1% globally for ESG excellence.

• Strategic focus on process intensification, capacity expansion, and broadening the product portfolio to reduce dependency on individual products.

• Proposed amalgamation of subsidiaries to unlock synergies and support scalable growth.

• Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, with statutory auditor's limited review and unmodified opinion.

Financial highlights

• Q2 FY2026 consolidated revenue: ₹67,871.43 lakhs (INR 678.82 crore), up 26% YoY; H1 FY2026 consolidated revenue: ₹1,23,752.67 lakhs (INR 1,246.08 crore), up 24% YoY.

• Q2 FY2026 EBITDA: ₹182.14 crore, up 59% YoY; H1 FY2026 EBITDA: ₹323.19 crore, up 53% YoY.

• Q2 FY2026 PAT: ₹90.21 crore (101% YoY growth); H1 FY2026 PAT: ₹147.76 crore (94% YoY growth).

• Q2 FY2026 EBITDA margin: 26.83%; PAT margin: 13.29%.

• Basic and diluted EPS (consolidated) for Q2 FY26: ₹24.04, up from ₹11.43 YoY; H1 FY26: ₹39.90, up from ₹19.46 YoY.

Outlook and guidance

• Revenue and EBITDA targets set at INR 5,000 crore and INR 1,000 crore, respectively, over the next 3-4 years, with expansion initiatives to enhance capacity by ~50%.

• EBITDA margin guidance maintained at 24-26%, including recurring state incentives.

• Demand outlook remains strong, supported by rising global consumption and sustainable innovation trends.

• Management and auditors confirm compliance with Indian Accounting Standards and SEBI regulations; no material misstatements identified.